The biology of influenza viruses NM Bouvier, P Palese Vaccine 26, D49-D53, 2008 | 1684 | 2008 |
Aerosol emission and superemission during human speech increase with voice loudness S Asadi, AS Wexler, CD Cappa, S Barreda, NM Bouvier, WD Ristenpart Scientific reports 9 (1), 1-10, 2019 | 1094 | 2019 |
The coronavirus pandemic and aerosols: Does COVID-19 transmit via expiratory particles? S Asadi, N Bouvier, AS Wexler, WD Ristenpart Aerosol Science and Technology 54 (6), 635-638, 2020 | 848 | 2020 |
Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study STH Liu, HM Lin, I Baine, A Wajnberg, JP Gumprecht, F Rahman, ... Nature medicine 26 (11), 1708-1713, 2020 | 533 | 2020 |
Animal models for influenza virus pathogenesis and transmission NM Bouvier, AC Lowen Viruses 2 (8), 1530-1565, 2010 | 469 | 2010 |
Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins MS Park, ML Shaw, J Munoz-Jordan, JF Cros, T Nakaya, N Bouvier, ... Journal of virology 77 (2), 1501-1511, 2003 | 459 | 2003 |
Efficacy of masks and face coverings in controlling outward aerosol particle emission from expiratory activities S Asadi, CD Cappa, S Barreda, AS Wexler, NM Bouvier, WD Ristenpart Scientific reports 10 (1), 1-13, 2020 | 409 | 2020 |
Environmental factors affecting the transmission of respiratory viruses N Pica, NM Bouvier Current opinion in virology 2 (1), 90-95, 2012 | 325 | 2012 |
The effect of convalescent plasma therapy on mortality among patients with COVID-19: systematic review and meta-analysis SA Klassen, JW Senefeld, PW Johnson, RE Carter, CC Wiggins, ... Mayo Clinic Proceedings 96 (5), 1262-1275, 2021 | 253* | 2021 |
Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational study A Wajnberg, M Mansour, E Leven, NM Bouvier, G Patel, ... The Lancet Microbe 1 (7), e283-e289, 2020 | 238* | 2020 |
Animal models for influenza virus pathogenesis, transmission, and immunology RR Thangavel, NM Bouvier Journal of immunological methods 410, 60-79, 2014 | 229 | 2014 |
Influenza A virus transmission bottlenecks are defined by infection route and recipient host A Varble, RA Albrecht, S Backes, M Crumiller, NM Bouvier, D Sachs, ... Cell host & microbe 16 (5), 691-700, 2014 | 214 | 2014 |
Effect of voicing and articulation manner on aerosol particle emission during human speech S Asadi, AS Wexler, CD Cappa, S Barreda, NM Bouvier, WD Ristenpart PloS one 15 (1), e0227699, 2020 | 205 | 2020 |
Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility R Hai, M Schmolke, VH Leyva-Grado, RR Thangavel, I Margine, EL Jaffe, ... Nature communications 4 (1), 2854, 2013 | 187 | 2013 |
Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins R Nachbagauer, A Choi, A Hirsh, I Margine, S Iida, A Barrera, M Ferres, ... Nature immunology 18 (4), 464-473, 2017 | 158 | 2017 |
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation A Rialdi, L Campisi, N Zhao, AC Lagda, C Pietzsch, JSY Ho, ... Science 352 (6289), aad7993, 2016 | 157 | 2016 |
Individuals with Down syndrome hospitalized with COVID-19 have more severe disease L Malle, C Gao, C Hur, HQ Truong, NM Bouvier, B Percha, XF Kong, ... Genetics in Medicine 23 (3), 576-580, 2021 | 112 | 2021 |
Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol NM Bouvier, AC Lowen, P Palese Journal of virology 82 (20), 10052-10058, 2008 | 110 | 2008 |
Influenza A virus is transmissible via aerosolized fomites S Asadi, N Gaaloul ben Hnia, RS Barre, AS Wexler, WD Ristenpart, ... Nature communications 11 (1), 4062, 2020 | 105 | 2020 |
An amphibian host defense peptide is virucidal for human H1 hemagglutinin-bearing influenza viruses DJ Holthausen, SH Lee, VTV Kumar, NM Bouvier, F Krammer, ... Immunity 46 (4), 587-595, 2017 | 105 | 2017 |